These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6110193)

  • 21. [Comparison of the effectiveness of triazolam (Halcion) and flunitrazepam (Rohypnol) in the preoperative period. A double blind crossover study].
    Heinzl H; Axhausen C; Bähler U; Gehrer H
    Schweiz Med Wochenschr; 1980 Nov; 110(46):1745-8. PubMed ID: 6111126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UK.
    Abraham J
    Soc Sci Med; 2002 Nov; 55(9):1671-90. PubMed ID: 12297251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
    Greenblatt DJ; Shader RI; Divoll M; Harmatz JS
    J Clin Psychiatry; 1984 May; 45(5):192-5. PubMed ID: 6144670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical reactions to hypnotic agents in adolescents with free-running disorder.
    Echizenya M; Iwaki S; Suda H; Shimizu T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):428. PubMed ID: 19566781
    [No Abstract]   [Full Text] [Related]  

  • 25. Inadvertent benzodiazepine withdrawal.
    Feldbaum JS
    Am Fam Physician; 1984 Oct; 30(4):46, 50. PubMed ID: 6149681
    [No Abstract]   [Full Text] [Related]  

  • 26. Anxiety caused by a short-life hypnotic.
    Br Med J (Clin Res Ed); 1982 Jun; 284(6331):1785-6. PubMed ID: 6123364
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experiences with triazolam (Halcion)].
    Enge A
    Tidsskr Nor Laegeforen; 1989 Aug; 109(23):2347-8. PubMed ID: 2772904
    [No Abstract]   [Full Text] [Related]  

  • 28. [Five years with the Institute of Rational Pharmacotherapy].
    Kampmann JP
    Ugeskr Laeger; 2005 Jan; 167(2):169-71. PubMed ID: 15697129
    [No Abstract]   [Full Text] [Related]  

  • 29. Physician acquisition of prescription drug information.
    Evans KR; Beltramini RF
    J Health Care Mark; 1986 Dec; 6(4):15-25. PubMed ID: 10280368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural reactions to triazolam.
    Barclay WR; Ayd FJ; Callan JP; Curran WJ; Gardner EA; Greenblatt DJ; Ladimer I; Lapierre Y; Lehmann HE; O'Donnell TJ; van Praag HM; Shader RI
    Lancet; 1979 Nov; 2(8150):1018. PubMed ID: 91745
    [No Abstract]   [Full Text] [Related]  

  • 31. First annual report of the New Zealand Preferred Medicines Centre 1993.
    Maling T; Ward C
    N Z Med J; 1993 Aug; 106(962):364-7. PubMed ID: 8255564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prescription shopping of addictive drugs in Norway].
    Winther RB; Bramness JG
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):517-20. PubMed ID: 19282887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do co-existing psychosocial problems influence the prescription of psychotropic medication in depressive and anxiety disorders?
    van Rijswijk E; Lucassen P; van De Lisdonk E; Zitman F; van Weel C
    Eur J Gen Pract; 2006; 12(1):37-9. PubMed ID: 16945871
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal intrahepatic cholestasis associated with triazolam.
    Cobden I; Record CO; White RW
    Postgrad Med J; 1981 Nov; 57(673):730-1. PubMed ID: 6122205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactions to triazolam.
    van der Kroef C
    Lancet; 1979 Sep; 2(8141):526. PubMed ID: 90240
    [No Abstract]   [Full Text] [Related]  

  • 36. Anxiety caused by a short-life hypnotic.
    Oswald I
    Br Med J (Clin Res Ed); 1982 Aug; 285(6340):511. PubMed ID: 6125233
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics.
    Bechelli LP; Navas F; Pierangelo SA
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():235-41. PubMed ID: 6145679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner].
    Niessen WJ; Stewart RE; Broer J; Haaijer-Ruskamp FM
    Ned Tijdschr Geneeskd; 2005 Feb; 149(7):356-61. PubMed ID: 15751808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the dependence-inducing potential of zopiclone and triazolam.
    Boissl K; Dreyfus JF; Delmotte M
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():242-7. PubMed ID: 6145680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of triazolam (Halcion).
    McCallum AB
    N Z Med J; 1991 Sep; 104(920):408. PubMed ID: 1923089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.